Patient preference for second & third-line therapies in Type 2 Diabetes

Patient preference for second & third-line therapies in Type 2 Diabetes

Jan

09:00 PM

In this edition of Diabetes Prime, join Dr. S.K Singh as he takes a deep-dive into why patient preference is vital in selecting medication. Don't miss out on these eye-opening insights!

Panelists

Dr.S. K. Singh

Professor and Head, Department of Endocrinology and Metabolism, Institute of Medical Science, Banaras, Hindu University, Varanasi

Patient preference for second & third-line therapies in Type 2 Diabetes

Jan

09:00 PM

In this edition of Diabetes Prime, join Dr. S.K Singh as he takes a deep-dive into why patient preference is vital in selecting medication. Don't miss out on these eye-opening insights!

Panelists

Dr.S. K. Singh

Professor and Head, Department of Endocrinology and Metabolism, Institute of Medical Science, Banaras, Hindu University, Varanasi

CONNECT WITH US

Archived Videos

Patient preference for second & third-line therapies in Type 2 Diabetes

Women exposed to phthalates are at increased risk of developing diabetes

Behavior change programs are linked to a 20% reduction in the risk of developing diabetes in adults with raised blood sugars or pre-diabetes

Infants who are born large for gestational age (LGA) are at risk for perinatal morbidity and metabolic complications

CONNECT WITH US

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ

About Us

Medtalks TV

Webinars

CMEs

Terms And Conditions

Conferences

Quick Links

Useful Links

Connect With Us